chr5-179272310-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_014244.5(ADAMTS2):c.688+601G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0273 in 152,294 control chromosomes in the GnomAD database, including 131 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.027 ( 131 hom., cov: 33)
Consequence
ADAMTS2
NM_014244.5 intron
NM_014244.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.166
Publications
5 publications found
Genes affected
ADAMTS2 (HGNC:218): (ADAM metallopeptidase with thrombospondin type 1 motif 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase. This proteinase excises the N-propeptide of the fibrillar procollagens types I-III and type V. Mutations in this gene cause Ehlers-Danlos syndrome type VIIC, a recessively inherited connective-tissue disorder. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
ADAMTS2 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndrome, dermatosparaxis typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, PanelApp Australia, Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0273 (4151/152294) while in subpopulation NFE AF = 0.0339 (2304/68024). AF 95% confidence interval is 0.0327. There are 131 homozygotes in GnomAd4. There are 2245 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 131 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADAMTS2 | NM_014244.5 | c.688+601G>A | intron_variant | Intron 3 of 21 | ENST00000251582.12 | NP_055059.2 | ||
| ADAMTS2 | NM_021599.4 | c.688+601G>A | intron_variant | Intron 3 of 10 | NP_067610.1 | |||
| ADAMTS2 | XM_047417895.1 | c.193+601G>A | intron_variant | Intron 2 of 20 | XP_047273851.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADAMTS2 | ENST00000251582.12 | c.688+601G>A | intron_variant | Intron 3 of 21 | 1 | NM_014244.5 | ENSP00000251582.7 | |||
| ADAMTS2 | ENST00000274609.5 | c.688+601G>A | intron_variant | Intron 3 of 10 | 1 | ENSP00000274609.5 | ||||
| ADAMTS2 | ENST00000518335.3 | c.688+601G>A | intron_variant | Intron 3 of 20 | 3 | ENSP00000489888.2 | ||||
| ADAMTS2 | ENST00000698889.1 | n.688+601G>A | intron_variant | Intron 3 of 20 | ENSP00000514008.1 |
Frequencies
GnomAD3 genomes AF: 0.0273 AC: 4151AN: 152176Hom.: 131 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
4151
AN:
152176
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0273 AC: 4151AN: 152294Hom.: 131 Cov.: 33 AF XY: 0.0302 AC XY: 2245AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
4151
AN:
152294
Hom.:
Cov.:
33
AF XY:
AC XY:
2245
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
251
AN:
41576
American (AMR)
AF:
AC:
191
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
40
AN:
3470
East Asian (EAS)
AF:
AC:
6
AN:
5174
South Asian (SAS)
AF:
AC:
31
AN:
4816
European-Finnish (FIN)
AF:
AC:
1292
AN:
10610
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2304
AN:
68024
Other (OTH)
AF:
AC:
35
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
208
416
623
831
1039
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.